|
Sign In to gain access to subscriptions and/or personal tools.
|
Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis
R HB Benedict
Department of Neurology, State University of New York (SUNY), Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA, Buffalo Neuroimaging Analysis Center, Buffalo, New York, USA, benedict{at}buffalo.cdu
I Fishman
Department of Neurology, State University of New York (SUNY), Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA
M M McClellan
Department of Neurology, State University of New York (SUNY), Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA
R Bakshi
Department of Neurology, State University of New York (SUNY), Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA, Buffalo Neuroimaging Analysis Center, Buffalo, New York, USA, Imaging Services at Kaleida Health, Buffalo, New York, USA
B Weinstock-Guttman
Department of Neurology, State University of New York (SUNY), Buffalo School of Medicine and Biomedical Sciences, Buffalo, New York, USA
Introduction: The Beck Depression Inventory-Fast Screen (BDI-FS) is a brief self-report inventory designed to evaluate depression in patients with medical illness. A s depressive disorder is especially prominent in multiple sclerosis (MS), a cost-effective procedure for identifying depressive disorder in MS is sorely needed. The BDI-FS may be useful in this regard although, to date, its validity in MS patients has not been assessed. Methods: Fifty-four consecutive MS patients were studied. A ll underwent psychological assessment, which included the BDI-FS and other self-report measures of depression. Forty-eight caregiver/informants were interviewed using the Neuorpsychiatric Inventory (NPI). Retrospective chart reviews were conducted by a single trained research assistant, blind to the results of psychological testing and interviews, to determine if antidepressant medications had been prescribed. Results: The BDI-FS was significantly correlated with other self-report measures of depression (P B-0.001) and with informant reported dysphoria (P B-0.01), In addition, BDI-FS scores discriminated MS patients undergoing treatment for depressive disorder from untreated MS patients (P =0.01). Conclusion: These data support the concurrent and discriminative validity of the BDI-FS in MS. A s the test is brief and not confounded with neurological symptoms, it is recommended for depression screening in this population.
Key Words: brief assessment • depression • discriminative validity • multiple sclerosis
Multiple Sclerosis, Vol. 9, No. 4,
393-396 (2003)
DOI: 10.1191/1352458503ms902oa
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
J. M. Bruce, A. S. Bruce, L. Hancock, and S. Lynch
Self-reported Memory Problems in Multiple Sclerosis: Influence of Psychiatric Status and Normative Dissociative Experiences
Arch Clin Neuropsychol,
February 1, 2010;
25(1):
39 - 48.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Drake, B. Weinstock-Guttman, S. Morrow, D. Hojnacki, F. Munschauer, and R. Benedict
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test
Multiple Sclerosis,
February 1, 2010;
16(2):
228 - 237.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Calabrese, F. Rinaldi, I. Mattisi, P. Grossi, A. Favaretto, M. Atzori, V. Bernardi, L. Barachino, C. Romualdi, L. Rinaldi, et al.
Widespread cortical thinning characterizes patients with MS with mild cognitive impairment
Neurology,
January 26, 2010;
74(4):
321 - 328.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Honarmand and A. Feinstein
Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients
Multiple Sclerosis,
December 1, 2009;
15(12):
1518 - 1524.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L Strober, J Englert, F Munschauer, B Weinstock-Guttman, S Rao, and R. Benedict
Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS
Multiple Sclerosis,
September 1, 2009;
15(9):
1077 - 1084.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Morrow, B Weinstock-Guttman, F. Munschauer, D Hojnacki, and R. Benedict
Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis
Multiple Sclerosis,
August 1, 2009;
15(8):
998 - 1005.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R H B Benedict, D Ramasamy, F Munschauer, B Weinstock-Guttman, and R Zivadinov
Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy
J. Neurol. Neurosurg. Psychiatry,
February 1, 2009;
80(2):
201 - 206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Vanotti, R. Benedict, L Acion, F Caceres, and and VANEM Workgroup
Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Argentina
Multiple Sclerosis,
February 1, 2009;
15(2):
244 - 250.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Benedict, J. Duquin, S Jurgensen, R. Rudick, J Feitcher, F. Munschauer, M. Panzara, and B Weinstock-Guttman
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire
Multiple Sclerosis,
August 1, 2008;
14(7):
940 - 946.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. K. Houtchens, R.H.B. Benedict, R. Killiany, J. Sharma, Z. Jaisani, B. Singh, B. Weinstock-Guttman, C. R.G. Guttmann, and R. Bakshi
Thalamic atrophy and cognition in multiple sclerosis
Neurology,
September 18, 2007;
69(12):
1213 - 1223.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H.B. Benedict, J. Bruce, M. G. Dwyer, B. Weinstock-Guttman, C. Tjoa, E. Tavazzi, F. E. Munschauer, and R. Zivadinov
Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis
Multiple Sclerosis,
July 1, 2007;
13(6):
722 - 730.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D C Mohr, S L Hart, L Julian, and E S Tasch
Screening for depression among patients with multiple sclerosis: two questions may be enough
Multiple Sclerosis,
March 1, 2007;
13(2):
215 - 219.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B A Parmenter, B Weinstock-Guttman, N Garg, F Munschauer, and R H. Benedict
Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test
Multiple Sclerosis,
January 1, 2007;
13(1):
52 - 57.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. H. B. Benedict, J. M. Bruce, M. G. Dwyer, N. Abdelrahman, S. Hussein, B. Weinstock-Guttman, N. Garg, F. Munschauer, and R. Zivadinov
Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
Arch Neurol,
September 1, 2006;
63(9):
1301 - 1306.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F A H van der Linden, J J Kragt, M Klein, H M van der Ploeg, C H Polman, and B M J Uitdehaag
Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use
J. Neurol. Neurosurg. Psychiatry,
December 1, 2005;
76(12):
1677 - 1681.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R J Siegert and D A Abernethy
Depression in multiple sclerosis: a review
J. Neurol. Neurosurg. Psychiatry,
April 1, 2005;
76(4):
469 - 475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Benedict, D. Cox, L. L Thompson, F. Foley, B. Weinstock-Guttman, and F. Munschauer
Reliable screening for neuropsychological impairment in multiple sclerosis
Multiple Sclerosis,
December 1, 2004;
10(6):
675 - 678.
[Abstract]
[PDF]
|
|
|
|
|
